CLINICAL STAGE IVA GASTRIC CANCER AJCC V8
Clinical trials for CLINICAL STAGE IVA GASTRIC CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new CLINICAL STAGE IVA GASTRIC CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for CLINICAL STAGE IVA GASTRIC CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Chemotherapy mist shows promise in targeting stomach, ovarian, and colon cancers
Disease control Recruiting nowThis early-stage trial is testing the safety of a new method called PIPAC, which turns chemotherapy into a fine mist and sprays it directly into the abdomen during a minimally invasive surgery. The study includes adults with ovarian, uterine, appendix, stomach, or colorectal canc…
Matched conditions: CLINICAL STAGE IVA GASTRIC CANCER AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 16, 2026 20:50 UTC
-
Custom-Made vaccine plus immunotherapy shows promise for advanced cancers
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, given alone or with the immunotherapy drug pembrolizumab, for people with advanced solid tumors (like breast, lung, or skin cancer). The goal is to see if the combination is safe and helps control t…
Matched conditions: CLINICAL STAGE IVA GASTRIC CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
New drug combo shows promise for tough stomach cancers
Disease control Recruiting nowThis early-phase study tests a combination of two drugs, pembrolizumab and lenvatinib, in 15 people with advanced stomach or gastroesophageal cancer that has spread or cannot be surgically removed. The goal is to see if the combo can shrink tumors by boosting the immune system an…
Matched conditions: CLINICAL STAGE IVA GASTRIC CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 12, 2026 12:06 UTC